UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Annals of oncology, 2015-07, Vol.26 (7), p.1481-1487

2015

Volltextzugriff (PDF)

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii736-viii736

2018

Volltextzugriff (PDF)

Pathological complete response after neoadjuvant pembrolizumab and radiation

Clinical and experimental dermatology, 2019-07, Vol.44 (5), p.570-573

2019

Volltextzugriff (PDF)

Characterization of a messenger RNA polynucleotide vaccine vector

Cancer research (Chicago, Ill.), 1995-04, Vol.55 (7), p.1397-1400

1995

Volltextzugriff (PDF)

Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine

Clinical cancer research, 2000-01, Vol.6 (1), p.34-41

2000

Volltextzugriff (PDF)

Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration

Clinical cancer research, 1999-09, Vol.5 (9), p.2330-2337

1999

Volltextzugriff (PDF)

Selected strategies to augment polynucleotide immunization

Gene therapy, 1996-01, Vol.3 (1), p.67

1996

Volltextzugriff (PDF)

Immune response to a carcinoembryonic antigen polynucleotide vaccine

Cancer research (Chicago, Ill.), 1994-03, Vol.54 (5), p.1164-1168

1994

Volltextzugriff (PDF)

Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen

Clinical cancer research, 1998-11, Vol.4 (11), p.2903-2912

1998

Volltextzugriff (PDF)

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Vaccine, 2004-01, Vol.22 (5-6), p.773-780

2004

Volltextzugriff (PDF)

Incorporation of β-globin untranslated regions into a Sindbis virus vector for augmentation of heterologous mRNA expression

Gene therapy, 1997-06, Vol.4 (6), p.624-627

1997

Volltextzugriff (PDF)

Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma

Human gene therapy, 2005, Vol.16 (1), p.91-100

2005

Volltextzugriff (PDF)

Polynucleotide-mediated immunization therapy of cancer

Seminars in oncology, 1996-02, Vol.23 (1), p.135

1996

Volltextzugriff (PDF)

Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen

Gene therapy, 1998-07, Vol.5 (7), p.865-868

1998

Volltextzugriff (PDF)

Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration

Journal of immunotherapy (1997), 1995-11, Vol.18 (4), p.231-241

1995

Volltextzugriff (PDF)

Characterization of poliovirus replicons encoding carcinoembryonic antigen

Cancer research (Chicago, Ill.), 1994-12, Vol.54 (24), p.6359-6364

1994

Volltextzugriff (PDF)

Human immune response to monoclonal antibodies

Journal of immunotherapy with emphasis on tumor immunology, 1994-01, Vol.15 (1), p.42

1994

Volltextzugriff (PDF)

Development of a polynucleotide vaccine from melanoma antigen recognized by T cells-1 and recombinant protein from melanoma antigen recognized by T cells-1 for melanoma vaccine clinical trials

Journal of immunotherapy, 2000-05, Vol.23 (3), p.379-386

2000

Volltextzugriff (PDF)

A carcinoembryonic antigen polynucleotide vaccine for human clinical use

Cancer gene therapy, 1995-03, Vol.2 (1), p.33

1995

Volltextzugriff (PDF)

Immunization with a plasmid expressing pneumococcal surface protein A (PsPa) can elicit protection against fatal infection with Streptococcus pneumoniae

Gene therapy, 1997-04, Vol.4 (4), p.375-377

1997

Volltextzugriff (PDF)

LBA45Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo

Nucleic acids research, 1995-05, Vol.23 (9), p.1495-1501

1995

Volltextzugriff (PDF)

Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors

Cancer gene therapy, 1994-12, Vol.1 (4), p.245-252

1994

Volltextzugriff (PDF)

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity

Gene therapy, 1995-01, Vol.2 (1), p.59

1995

Volltextzugriff (PDF)

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma

Journal of the American Academy of Dermatology, 2012-12, Vol.67 (6), p.1375-1379

2012

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(195)
Tagungsberichte
(1)

Sprache

Englisch
(196)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Pathological complete response after neoadjuvant pembrolizumab and radiation

Characterization of a messenger RNA polynucleotide vaccine vector

Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine

Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration

Selected strategies to augment polynucleotide immunization

Immune response to a carcinoembryonic antigen polynucleotide vaccine

Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Incorporation of β-globin untranslated regions into a Sindbis virus vector for augmentation of heterologous mRNA expression

Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma

Polynucleotide-mediated immunization therapy of cancer

Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen

Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration

Characterization of poliovirus replicons encoding carcinoembryonic antigen

Human immune response to monoclonal antibodies

Development of a polynucleotide vaccine from melanoma antigen recognized by T cells-1 and recombinant protein from melanoma antigen recognized by T cells-1 for melanoma vaccine clinical trials

A carcinoembryonic antigen polynucleotide vaccine for human clinical use

Immunization with a plasmid expressing pneumococcal surface protein A (PsPa) can elicit protection against fatal infection with Streptococcus pneumoniae

LBA45Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo

Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma

Suchergebnisse filtern